Back to Agenda
Session 5: Where Next? Panel Discussion
Session Chair(s)
Jürgen Kübler, PhD
Owner
Quantitative Scientific Consulting, Germany
Speaker(s)
Sigrid Behr, PhD
Novartis Pharma AG, Switzerland
Group Head Quantitative Safety & Epidemiology
Hans Ulrich Burger, PhD
F. Hoffmann-La Roche Ltd., Switzerland
Senior Director of Biostatistics
Stephen JW Evans, MSc, FRCP
The London School of Hygiene & Tropical Medicine, United Kingdom
Professor of Pharmacoepidemiology
Robert Hemmings, MSc
Critical Path Institute, United States
Partner
Olaf Klungel, MPharm
Utrecht University, Faculty of Science, Netherlands
Professor of Pharmacoepidemiologic Methods
Mark Levenson, PhD
FDA, United States
Director, Division of Biometrics VII, Office of Biostatistics, OT, CDER
Anja Schiel, PhD
Norwegian Medicines Agency (NoMA), Norway
Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA
Jim Slattery, MSc
European Medicines Agency, Netherlands
Statistician, Pharmacovigilance Department
Have an account?